Also, Protein Sciences Corp. of Meriden, Conn., landed a five-year, $147 million contract to develop a vaccine using its recombinant technology — flu proteins grown in insect cells. The hope is that the first doses would be available within 12 weeks of the beginning of a pandemic. That is about twice as fast as flu vaccine produced from eggs.
Contents contributed and discussions participated by Casey Finnerty
J Gen Virol - 0 views
J Virol - 0 views
Virology - 0 views
Virology Journal - 0 views
A virus so large it gets viruses - 2 views
Ebola drugs: Agents block Ebola, Marburg viruses in tests - chicagotribune.com - 0 views
A Gazillion Tiny Avatars - Opinionator Blog - NYTimes.com - 0 views
Op-Ed Contributor - A Case of Chronic Denial - NYTimes.com - 0 views
-
Article about XMRV and chronic fatigue syndrome
Chicagoan follows father's footsteps to Purdue, discovers new virus - chicagotribune.com - 0 views
-
"National Genomics Research Initiative"
Animal Cell Entry - 0 views
Five myths about HIV and AIDS - health - 23 June 2009 - New Scientist - 0 views
« First
‹ Previous
661 - 680 of 737
Next ›
Last »
Showing 20▼ items per page
Casey Finnerty